Skip to main content
. 2022 Oct 21;13:909945. doi: 10.3389/fphar.2022.909945

TABLE 2.

Proposed deglucuronidation-based antiviral mechanism.

Stage A—Infection by any of several virus species induces inflammation
Stage B—Flavonoid aglycones are glucuronidated prior to arrival in the bloodstream
Stage C—Neutrophils and macrophages are attracted to site(s) of inflammation
Stage D—β-glucuronidase is expressed by neutrophils and macrophages
Stage E—Serum flavonoid glucuronides are deglucuronidated (“deconjugated”) by β-glucuronidase at site of inflammation
Stage F—Flavonoid aglycones diffuse through cell membrane
Stage G—Flavonoid aglycones cause non-selective (and non-specific) inhibition within the cell—interfering with both ordinary cellular processes and the etiological source of inflammation (such as viral replication)